 | Form 4 Filings | Insider Buys | Significant Buys | Penny Stocks Insider Buying | Insider Sales |
| Insider Buy Sell Ratios | Stock Options | Insider Trading Stock Screener | Insider Trading Graph View | Insider Watch |
Insider Trading - UroGen Pharma Ltd. (URGN)
| | "Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise" - Peter Lynch What is insider trading>> SPAC List: List of Special Purpose Acquisition Companies |
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2020-02-14 Sale | 2020-02-18 2:33 pm | UroGen Pharma Ltd. | URGN | Mullennix Stephen COO | 612 | $28.04 | $17,160 | 9,812 (Direct) | View |
| 2020-02-20 Sale | 2020-02-24 4:53 pm | UroGen Pharma Ltd. | URGN | PFREUNDSCHUH PETER P. CFO | 360 | $29.68 | $10,685 | 6,120 (Direct) | View |
| 2020-04-26 Sale | 2020-04-28 1:43 pm | UroGen Pharma Ltd. | URGN | Mullennix Stephen COO | 145 | $24.35 | $3,531 | 10,084 (Direct) | View |
| 2020-04-26 Sale | 2020-04-28 1:51 pm | UroGen Pharma Ltd. | URGN | PFREUNDSCHUH PETER P. CFO | 141 | $24.35 | $3,433 | 6,396 (Direct) | View |
| 2020-04-26 Sale | 2020-04-28 1:53 pm | UroGen Pharma Ltd. | URGN | Schoenberg Mark Chief Medical Officer | 70 | $24.35 | $1,705 | 17,711 (Direct) | View |
| 2020-05-20 Sale | 2020-05-20 4:44 pm | UroGen Pharma Ltd. | URGN | PFREUNDSCHUH PETER P. CFO | 358 | $25.07 | $8,975 | 7,079 (Direct) | View |
| 2020-06-04 Sale | 2020-06-05 2:31 pm | UroGen Pharma Ltd. | URGN | Schoenberg Mark Chief Medical Officer | 349 | $27.51 | $9,602 | 18,404 (Direct) | View |
| 2020-07-26 Sale | 2020-07-28 5:32 pm | UroGen Pharma Ltd. | URGN | Schoenberg Mark Chief Medical Officer | 70 | $23.51 | $1,646 | 18,543 (Direct) | View |
| 2020-07-26 Sale | 2020-07-28 5:34 pm | UroGen Pharma Ltd. | URGN | PFREUNDSCHUH PETER P. CFO | 141 | $23.51 | $3,315 | 7,355 (Direct) | View |
| 2020-09-01 Sale | 2020-09-01 2:37 pm | UroGen Pharma Ltd. | URGN | PFREUNDSCHUH PETER P. CFO | 509 | $22.82 | $11,615 | 7,888 (Direct) | View |
| 2020-09-04 Sale | 2020-09-08 4:48 pm | UroGen Pharma Ltd. | URGN | Schoenberg Mark Chief Medical Officer | 348 | $20.2 | $7,030 | 19,236 (Direct) | View |
| 2020-10-15 Sale | 2020-10-16 3:41 pm | UroGen Pharma Ltd. | URGN | PFREUNDSCHUH PETER P. CFO | 2,400 | $21.77 | $52,248 | 10,405 (Direct) | View |
| 2020-10-26 Sale | 2020-10-28 2:12 pm | UroGen Pharma Ltd. | URGN | Schoenberg Mark Chief Medical Officer | 101 | $20.95 | $2,116 | 19,343 (Direct) | View |
| 2020-12-04 Sale | 2020-12-07 3:59 pm | UroGen Pharma Ltd. | URGN | Schoenberg Mark Chief Medical Officer | 662 | $19.85 | $13,141 | 19,723 (Direct) | View |
| 2020-12-14 Purchase | 2020-12-15 5:27 pm | UroGen Pharma Ltd. | URGN | Barrett Elizabeth A. CEO | 10,000 | $18.5 | $185,000 | 229,117 (Direct) | View |
| 2021-01-26 Sale | 2021-01-26 5:20 pm | UroGen Pharma Ltd. | URGN | Schoenberg Mark Chief Medical Officer | 100 | $22.12 | $2,212 | 19,831 (Direct) | View |
| 2021-02-02 Sale | 2021-02-02 2:53 pm | UroGen Pharma Ltd. | URGN | Schoenberg Mark Chief Medical Officer | 1,076 | $22.07 | $23,747 | 20,755 (Direct) | View |
| 2021-04-26 Sale | 2021-04-27 1:44 pm | UroGen Pharma Ltd. | URGN | Schoenberg Mark Chief Medical Officer | 89 | $19.63 | $1,747 | 20,875 (Direct) | View |
| 2021-04-30 Sale | 2021-05-04 1:58 pm | UroGen Pharma Ltd. | URGN | Schoenberg Mark Chief Medical Officer | 243 | $20 | $4,860 | 21,132 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2020-01-31 Option Award | 2020-02-04 12:38 pm | N/A N/A | UroGen Pharma Ltd. | URGN | Schoenberg Mark Chief Medical Officer | 15,000 | $0 | 15,000 (Direct) | View |
| 2020-01-31 Option Award | 2020-02-04 12:38 pm | N/A N/A | UroGen Pharma Ltd. | URGN | Schoenberg Mark Chief Medical Officer | 6,000 | $0 | 6,000 (Direct) | View |
| 2020-01-31 Option Award | 2020-02-04 12:39 pm | N/A N/A | UroGen Pharma Ltd. | URGN | Mullennix Stephen COO | 15,000 | $0 | 15,000 (Direct) | View |
| 2020-01-31 Option Award | 2020-02-04 12:39 pm | N/A N/A | UroGen Pharma Ltd. | URGN | Mullennix Stephen COO | 3,000 | $0 | 3,000 (Direct) | View |
| 2020-01-31 Option Award | 2020-02-04 12:40 pm | N/A N/A | UroGen Pharma Ltd. | URGN | PFREUNDSCHUH PETER P. CFO | 15,000 | $0 | 15,000 (Direct) | View |
| 2020-01-31 Option Award | 2020-02-04 12:40 pm | N/A N/A | UroGen Pharma Ltd. | URGN | PFREUNDSCHUH PETER P. CFO | 6,000 | $0 | 6,000 (Direct) | View |
| 2020-02-14 Exercise | 2020-02-18 2:33 pm | N/A N/A | UroGen Pharma Ltd. | URGN | Mullennix Stephen COO | 1,759 | $0 | 10,424 (Direct) | View |
| 2020-02-14 Exercise | 2020-02-18 2:33 pm | N/A N/A | UroGen Pharma Ltd. | URGN | Mullennix Stephen COO | 1,759 | $0 | 7,037 (Direct) | View |
| 2020-02-20 Exercise | 2020-02-24 4:53 pm | N/A N/A | UroGen Pharma Ltd. | URGN | PFREUNDSCHUH PETER P. CFO | 1,042 | $0 | 6,480 (Direct) | View |
| 2020-02-20 Exercise | 2020-02-24 4:53 pm | N/A N/A | UroGen Pharma Ltd. | URGN | PFREUNDSCHUH PETER P. CFO | 1,042 | $0 | 6,249 (Direct) | View |
| 2020-03-04 Exercise | 2020-03-04 5:28 pm | N/A N/A | UroGen Pharma Ltd. | URGN | Schoenberg Mark Chief Medical Officer | 1,042 | $0 | 17,918 (Direct) | View |
| 2020-03-04 Tax Withholding | 2020-03-04 5:28 pm | N/A N/A | UroGen Pharma Ltd. | URGN | Schoenberg Mark Chief Medical Officer | 345 | $29.5 | 17,573 (Direct) | View |
| 2020-03-04 Exercise | 2020-03-04 5:28 pm | N/A N/A | UroGen Pharma Ltd. | URGN | Schoenberg Mark Chief Medical Officer | 1,042 | $0 | 3,125 (Direct) | View |
| 2020-04-26 Exercise | 2020-04-28 1:43 pm | N/A N/A | UroGen Pharma Ltd. | URGN | Mullennix Stephen COO | 417 | $0 | 10,229 (Direct) | View |
| 2020-04-26 Exercise | 2020-04-28 1:43 pm | N/A N/A | UroGen Pharma Ltd. | URGN | Mullennix Stephen COO | 417 | $0 | 2,917 (Direct) | View |
| 2020-04-26 Exercise | 2020-04-28 1:51 pm | N/A N/A | UroGen Pharma Ltd. | URGN | PFREUNDSCHUH PETER P. CFO | 417 | $0 | 6,537 (Direct) | View |
| 2020-04-26 Exercise | 2020-04-28 1:51 pm | N/A N/A | UroGen Pharma Ltd. | URGN | PFREUNDSCHUH PETER P. CFO | 417 | $0 | 2,917 (Direct) | View |
| 2020-04-26 Exercise | 2020-04-28 1:53 pm | N/A N/A | UroGen Pharma Ltd. | URGN | Schoenberg Mark Chief Medical Officer | 208 | $0 | 17,781 (Direct) | View |
| 2020-04-26 Exercise | 2020-04-28 1:53 pm | N/A N/A | UroGen Pharma Ltd. | URGN | Schoenberg Mark Chief Medical Officer | 208 | $0 | 1,459 (Direct) | View |
| 2020-05-12 Exercise | 2020-05-14 1:07 pm | N/A N/A | UroGen Pharma Ltd. | URGN | Barrett Elizabeth A. CEO | 35,229 | $0 | 157,465 (Direct) | View |
| 2020-05-12 Exercise | 2020-05-14 1:07 pm | N/A N/A | UroGen Pharma Ltd. | URGN | Barrett Elizabeth A. CEO | 35,229 | $0 | 176,148 (Direct) | View |
| 2020-05-20 Exercise | 2020-05-20 4:44 pm | N/A N/A | UroGen Pharma Ltd. | URGN | PFREUNDSCHUH PETER P. CFO | 1,041 | $0 | 7,437 (Direct) | View |
| 2020-05-20 Exercise | 2020-05-20 4:44 pm | N/A N/A | UroGen Pharma Ltd. | URGN | PFREUNDSCHUH PETER P. CFO | 1,041 | $0 | 5,208 (Direct) | View |
| 2020-06-04 Exercise | 2020-06-05 2:31 pm | N/A N/A | UroGen Pharma Ltd. | URGN | Schoenberg Mark Chief Medical Officer | 1,042 | $0 | 18,753 (Direct) | View |
| 2020-06-04 Exercise | 2020-06-05 2:31 pm | N/A N/A | UroGen Pharma Ltd. | URGN | Schoenberg Mark Chief Medical Officer | 1,042 | $0 | 2,083 (Direct) | View |
| 2020-06-08 Option Award | 2020-06-10 6:35 pm | N/A 2030-06-07 | UroGen Pharma Ltd. | URGN | Belldegrun Arie Director | 10,000 | $0 | 10,000 (Direct) | View |
| 2020-06-08 Option Award | 2020-06-10 6:36 pm | N/A 2030-06-07 | UroGen Pharma Ltd. | URGN | BUTITTA CYNTHIA M Director | 10,000 | $0 | 10,000 (Direct) | View |
| 2020-06-08 Option Award | 2020-06-10 6:38 pm | N/A 2030-06-07 | UroGen Pharma Ltd. | URGN | Cohen Fred E Director | 10,000 | $0 | 10,000 (Direct) | View |
| 2020-06-08 Option Award | 2020-06-10 6:39 pm | N/A 2030-06-07 | UroGen Pharma Ltd. | URGN | FALBERG KATHRYN E Director | 10,000 | $0 | 10,000 (Direct) | View |
| 2020-06-08 Option Award | 2020-06-10 6:40 pm | N/A 2030-06-07 | UroGen Pharma Ltd. | URGN | Holden Stuart Director | 10,000 | $0 | 10,000 (Direct) | View |
| 2020-06-08 Option Award | 2020-06-10 6:41 pm | N/A 2030-06-07 | UroGen Pharma Ltd. | URGN | Nussbaum Ran Director | 10,000 | $0 | 10,000 (Direct) | View |
| 2020-06-08 Option Award | 2020-06-10 6:43 pm | N/A 2030-06-07 | UroGen Pharma Ltd. | URGN | Tomasello Shawn Director | 10,000 | $0 | 10,000 (Direct) | View |
| 2020-07-26 Exercise | 2020-07-28 5:32 pm | N/A N/A | UroGen Pharma Ltd. | URGN | Schoenberg Mark Chief Medical Officer | 209 | $0 | 18,613 (Direct) | View |
| 2020-07-26 Exercise | 2020-07-28 5:32 pm | N/A N/A | UroGen Pharma Ltd. | URGN | Schoenberg Mark Chief Medical Officer | 209 | $0 | 1,250 (Direct) | View |
| 2020-07-26 Exercise | 2020-07-28 5:34 pm | N/A N/A | UroGen Pharma Ltd. | URGN | PFREUNDSCHUH PETER P. CFO | 417 | $0 | 7,496 (Direct) | View |
| 2020-07-26 Exercise | 2020-07-28 5:34 pm | N/A N/A | UroGen Pharma Ltd. | URGN | PFREUNDSCHUH PETER P. CFO | 417 | $0 | 2,500 (Direct) | View |
| 2020-09-01 Exercise | 2020-09-01 2:37 pm | N/A N/A | UroGen Pharma Ltd. | URGN | PFREUNDSCHUH PETER P. CFO | 1,042 | $0 | 8,397 (Direct) | View |
| 2020-09-01 Exercise | 2020-09-01 2:37 pm | N/A N/A | UroGen Pharma Ltd. | URGN | PFREUNDSCHUH PETER P. CFO | 1,042 | $0 | 4,166 (Direct) | View |
| 2020-09-04 Exercise | 2020-09-08 4:48 pm | N/A N/A | UroGen Pharma Ltd. | URGN | Schoenberg Mark Chief Medical Officer | 1,041 | $0 | 19,584 (Direct) | View |
| 2020-09-04 Exercise | 2020-09-08 4:48 pm | N/A N/A | UroGen Pharma Ltd. | URGN | Schoenberg Mark Chief Medical Officer | 1,041 | $0 | 1,042 (Direct) | View |
| 2020-09-09 Option Award | 2020-09-10 12:14 pm | N/A 2030-09-08 | UroGen Pharma Ltd. | URGN | Smith Jason Drew General Counsel | 60,000 | $0 | 60,000 (Direct) | View |
| 2020-09-09 Option Award | 2020-09-10 12:14 pm | N/A N/A | UroGen Pharma Ltd. | URGN | Smith Jason Drew General Counsel | 25,000 | $0 | 25,000 (Direct) | View |
| 2020-10-01 Option Award | 2020-10-05 4:35 pm | N/A 2030-09-30 | UroGen Pharma Ltd. | URGN | Smith Jason Drew General Counsel | 60,000 | $0 | 60,000 (Direct) | View |
| 2020-10-01 Option Award | 2020-10-05 4:35 pm | N/A N/A | UroGen Pharma Ltd. | URGN | Smith Jason Drew General Counsel | 25,000 | $0 | 25,000 (Direct) | View |
| 2020-10-01 Option Award | 2020-10-05 4:37 pm | N/A 2030-09-30 | UroGen Pharma Ltd. | URGN | Henderson Molly CFO | 60,000 | $0 | 60,000 (Direct) | View |
| 2020-10-01 Option Award | 2020-10-05 4:37 pm | N/A N/A | UroGen Pharma Ltd. | URGN | Henderson Molly CFO | 15,000 | $0 | 15,000 (Direct) | View |
| 2020-10-15 Exercise | 2020-10-16 3:41 pm | N/A N/A | UroGen Pharma Ltd. | URGN | PFREUNDSCHUH PETER P. CFO | 4,917 | $0 | 12,805 (Direct) | View |
| 2020-10-15 Exercise | 2020-10-16 3:41 pm | N/A N/A | UroGen Pharma Ltd. | URGN | PFREUNDSCHUH PETER P. CFO | 833 | $0 | 1,667 (Direct) | View |
| 2020-10-15 Exercise | 2020-10-16 3:41 pm | N/A N/A | UroGen Pharma Ltd. | URGN | PFREUNDSCHUH PETER P. CFO | 2,084 | $0 | 2,082 (Direct) | View |
| 2020-10-15 Exercise | 2020-10-16 3:41 pm | N/A N/A | UroGen Pharma Ltd. | URGN | PFREUNDSCHUH PETER P. CFO | 2,000 | $0 | 4,000 (Direct) | View |
| 2020-10-26 Exercise | 2020-10-28 2:12 pm | N/A N/A | UroGen Pharma Ltd. | URGN | Schoenberg Mark Chief Medical Officer | 208 | $0 | 19,444 (Direct) | View |
| 2020-10-26 Exercise | 2020-10-28 2:12 pm | N/A N/A | UroGen Pharma Ltd. | URGN | Schoenberg Mark Chief Medical Officer | 208 | $0 | 1,042 (Direct) | View |
| 2020-12-04 Exercise | 2020-12-04 4:35 pm | N/A N/A | UroGen Pharma Ltd. | URGN | Barrett Elizabeth A. CEO | 61,652 | $0 | 219,117 (Direct) | View |
| 2020-12-04 Exercise | 2020-12-04 4:35 pm | N/A N/A | UroGen Pharma Ltd. | URGN | Barrett Elizabeth A. CEO | 61,652 | $0 | 114,496 (Direct) | View |
| 2020-12-04 Exercise | 2020-12-07 3:59 pm | N/A N/A | UroGen Pharma Ltd. | URGN | Schoenberg Mark Chief Medical Officer | 1,042 | $0 | 20,385 (Direct) | View |
| 2020-12-04 Exercise | 2020-12-07 3:59 pm | N/A N/A | UroGen Pharma Ltd. | URGN | Schoenberg Mark Chief Medical Officer | 1,042 | $0 | 0 (Direct) | View |
| 2021-01-26 Exercise | 2021-01-26 5:20 pm | N/A N/A | UroGen Pharma Ltd. | URGN | Schoenberg Mark Chief Medical Officer | 208 | $0 | 19,931 (Direct) | View |
| 2021-01-26 Exercise | 2021-01-26 5:20 pm | N/A N/A | UroGen Pharma Ltd. | URGN | Schoenberg Mark Chief Medical Officer | 208 | $0 | 834 (Direct) | View |
| 2021-02-02 Exercise | 2021-02-02 2:53 pm | N/A N/A | UroGen Pharma Ltd. | URGN | Schoenberg Mark Chief Medical Officer | 2,000 | $0 | 21,831 (Direct) | View |
| 2021-02-02 Exercise | 2021-02-02 2:53 pm | N/A N/A | UroGen Pharma Ltd. | URGN | Schoenberg Mark Chief Medical Officer | 2,000 | $0 | 4,000 (Direct) | View |
| 2021-02-02 Option Award | 2021-02-02 2:53 pm | N/A 2031-01-31 | UroGen Pharma Ltd. | URGN | Schoenberg Mark Chief Medical Officer | 21,000 | $0 | 21,000 (Direct) | View |
| 2021-02-02 Option Award | 2021-02-02 2:53 pm | N/A N/A | UroGen Pharma Ltd. | URGN | Schoenberg Mark Chief Medical Officer | 6,000 | $0 | 6,000 (Direct) | View |
| 2021-01-31 Option Award | 2021-02-02 2:54 pm | N/A 2031-01-31 | UroGen Pharma Ltd. | URGN | Barrett Elizabeth A. CEO | 150,000 | $0 | 150,000 (Direct) | View |
| 2021-01-31 Option Award | 2021-02-02 2:54 pm | N/A N/A | UroGen Pharma Ltd. | URGN | Barrett Elizabeth A. CEO | 40,000 | $0 | 40,000 (Direct) | View |
| 2021-01-31 Option Award | 2021-02-02 3:55 pm | N/A 2031-01-30 | UroGen Pharma Ltd. | URGN | Smith Jason Drew General Counsel | 8,000 | $0 | 8,000 (Direct) | View |
| 2021-01-31 Option Award | 2021-02-02 3:55 pm | N/A N/A | UroGen Pharma Ltd. | URGN | Smith Jason Drew General Counsel | 2,500 | $0 | 2,500 (Direct) | View |
| 2021-01-31 Option Award | 2021-02-02 3:57 pm | N/A 2031-01-30 | UroGen Pharma Ltd. | URGN | Henderson Molly CFO | 6,000 | $0 | 6,000 (Direct) | View |
| 2021-01-31 Option Award | 2021-02-02 3:57 pm | N/A N/A | UroGen Pharma Ltd. | URGN | Henderson Molly CFO | 2,000 | $0 | 2,000 (Direct) | View |
| 2021-03-24 Exercise | 2021-04-22 5:18 pm | N/A N/A | UroGen Pharma Ltd. | URGN | Nussbaum Ran Director | 1,030 | $5 | 1,465,199 (Indirect) | View |
| 2021-03-24 Exercise | 2021-04-22 5:18 pm | 2014-07-27 2021-07-27 | UroGen Pharma Ltd. | URGN | Nussbaum Ran Director | 1,030 | $0 | 0 (Indirect) | View |
| 2021-03-24 Exercise | 2021-04-22 5:19 pm | N/A N/A | UroGen Pharma Ltd. | URGN | Belldegrun Arie Director | 3,241 | $5 | 245,452 (Direct) | View |
| 2021-03-24 Exercise | 2021-04-22 5:19 pm | 2014-07-27 2021-07-27 | UroGen Pharma Ltd. | URGN | Belldegrun Arie Director | 3,241 | $0 | 0 (Direct) | View |
| 2021-04-26 Exercise | 2021-04-27 1:44 pm | N/A N/A | UroGen Pharma Ltd. | URGN | Schoenberg Mark Chief Medical Officer | 209 | $0 | 20,964 (Direct) | View |
| 2021-04-26 Exercise | 2021-04-27 1:44 pm | N/A N/A | UroGen Pharma Ltd. | URGN | Schoenberg Mark Chief Medical Officer | 209 | $0 | 625 (Direct) | View |
| 2021-04-30 Exercise | 2021-05-04 1:58 pm | N/A N/A | UroGen Pharma Ltd. | URGN | Schoenberg Mark Chief Medical Officer | 500 | $0 | 21,375 (Direct) | View |
| 2021-04-30 Exercise | 2021-05-04 1:58 pm | N/A N/A | UroGen Pharma Ltd. | URGN | Schoenberg Mark Chief Medical Officer | 500 | $0 | 3,500 (Direct) | View |